“The existing circumstance has uncovered some structural weaknesses from the EU’s medicines supply chain along with a high dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides said. She advised that supply chain problems be addressed in an EU pharmaceutical strategy expected being released by the tip on the year. https://apipowder94826.ambien-blog.com/36139240/getting-my-raw-materials-to-work